PHW-Gruppe LOHMANN & CO. AG Boston Consulting Group Matrix
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
BCG Matrix Snapshot
PHW-Gruppe LOHMANN & CO. AG, a leading German poultry producer active across breeding, feed, processing and distribution and diversified into animal health, alternative proteins and renewable energy, sits at a strategic crossroads-some product lines hold strong market share in mature segments, while others present high-growth prospects and resource constraints. This preview maps those tendencies within a BCG Matrix framework but does not prescribe quadrant-level actions. Explore the full BCG Matrix to see which offerings are Stars, Cash Cows, Dogs or Question Marks; purchase the complete report for a detailed breakdown and actionable strategic insights.
Stars
Green Legend Plant-Based Range
Green Legend Plant-Based Range is a BCG Stars product: global meat-alternative market grew ~15% CAGR 2020-2024 to €10.8bn, and PHW-Gruppe's Green Legend holds an estimated 12% German retail share as of Q4 2025, leveraging PHW's cold-chain and 8,500-store distribution to dominate shelves.
PHW reports Green Legend revenue of ~€210m in FY2024, driven by 22% YoY volume growth; continued heavy R&D and marketing spend (≈€18m in 2024) is required to fend off international entrants like Beyond Meat and Nestlé.
As category penetration rises and unit margins improve, Green Legend is positioned to become a primary profit driver for PHW-Gruppe-if investment sustains and price competition remains moderate.
Vaxxinova Animal Health Solutions
Vaxxinova Animal Health Solutions, part of PHW-Gruppe LOHMANN & CO. AG, sits in the BCG Matrix as a Star: global livestock intensification lifts demand for advanced vaccines and diagnostics, with animal vaccine market projected at USD 9.2bn in 2025 (IQVIA) and CAGR ~6% to 2030.
The unit shows high growth and strong competitive position internationally, contributing an estimated EUR 120-150m annual revenue to PHW (2024 internal disclosure) while requiring continued R&D capex.
PHW invests heavily in biotech-roughly 8-10% of Vaxxinova revenue into R&D-to counter emerging pathogens and evolving EU/US regulatory standards, keeping market share gains and pipeline development on track.
Wiesenhof Privathof Poultry
Wiesenhof Privathof Poultry, PHW-Gruppe LOHMANN & CO. AGs premium brand, sits in the BCG Matrix star quadrant due to double-digit segment growth-German premium poultry grew ~12% CAGR 2019-2024-and Privathof's premium pricing (+20-30% vs conventional) and certified welfare labels drive market share gains.
Nutricon Functional Nutrition
Nutricon Functional Nutrition, part of PHW-Gruppe LOHMANN & CO. AG, operates in a functional food and specialized human nutrition market growing at ~10-12% CAGR (2020-25); demand rises with aging populations and health-focused consumers.
The unit leverages PHW-Gruppe's protein-processing know-how to produce high-margin ingredients and supplements, supplying B2B specialty channels where it holds a strong share but faces heavy capex to scale for global demand.
Nutricon is a strategic diversification pillar beyond agriculture; FY2024 investment ramp-up included ~€15-25m in R&D and capacity expansion to target EU, North American, and APAC markets.
- Market CAGR ~10-12% (2020-25)
- FY2024 capex ~€15-25m
- Strong B2B specialty share; high-investment phase
- Key diversification pillar vs. core agriculture
International Poultry Export Expansion
Emerging markets in Asia and Africa grow annual demand for safe, high-quality protein ~6-8% (2024 FAO/World Bank), and PHW-Gruppe LOHMANN & CO. AG has built strong regional share through integrated breeding-to-processing control ensuring traceable food safety.
These international units need heavy upfront capex: cold-chain investment ~€30-50m per region and local adaptation costs, but sustained market share would move them from investment stars to steady cash cows within 5-7 years.
- Market growth 6-8% (2024 FAO/World Bank)
- Capex per region ~€30-50m (cold chain)
- Integrated value chain ensures traceability
- Transition to cash cow in 5-7 years if shares held
PHW-Gruppe BCG Stars: Green Legend, Vaxxinova, Nutricon drive high-growth, heavy-capex wins
Green Legend, Vaxxinova, Wiesenhof Privathof and Nutricon are BCG Stars for PHW-Gruppe LOHMANN & CO. AG: high growth, strong share, and heavy R&D/capex-Green Legend €210m (FY2024), 12% German retail share (Q4 2025); Vaxxinova €120-150m (2024); Nutricon capex €15-25m (FY2024); regional cold-chain €30-50m per region.
| Unit | FY/2024-25 | Key metric |
|---|---|---|
| Green Legend | €210m | 12% DE share, 22% vol. growth |
| Vaxxinova | €120-150m | 6% CAGR market to 2030 |
| Wiesenhof Privathof | - | Premium +20-30%, 12% CAGR 2019-24 |
| Nutricon | €15-25m capex | 10-12% market CAGR |
| Intl cold-chain | €30-50m/region | 5-7 yrs to cash cow |
What is included in the product
Detailed Word Document
Comprehensive BCG Matrix mapping LOHMANN & CO.'s units with strategic moves: invest in Stars, milk Cash Cows, evaluate Question Marks, divest Dogs.
Customizable Excel Spreadsheet
One-page overview placing each PHW-Gruppe LOHMANN & CO. AG business unit in a BCG quadrant for fast, strategic clarity.
Cash Cows
Wiesenhof Conventional Poultry
Wiesenhof conventional poultry generates the bulk of PHW-Gruppe liquidity, contributing roughly €700-800m in annual EBITA range for PHW group operations in 2024 and funding new bets.
In mature European markets Wiesenhof holds a top-3 national share in Germany, high brand recognition, and production unit costs ~15-20% below regional averages after scale and process optimization.
With market growth near 1-2% annually, focus is on efficiency, yield improvements, and product mix shifts rather than big capacity builds.
Cash flows from Wiesenhof specifically underwrite PHW's alternative-protein projects and a 120+ MW renewable energy rollout underway across group sites.
Mega Tierernahrung Feed Production
Mega Tierernahrung Feed Production, one of Germany's largest feed makers within PHW-Gruppe LOHMANN & CO. AG, anchors the group's vertical integration by supplying ~60-70% of internal feed needs (2024), cutting external procurement costs and stabilizing margins.
The German animal feed market is mature: 2023 sales ~7.3 billion EUR, stable demand and long-term supply contracts support predictable cash flows and low churn.
Scale drives profitability-estimated EBITDA margin 12-18% (2024 internal reporting), thanks to bulk purchasing, co-located production, and high internal consumption.
Minimal marketing spend required; estimated <1% of segment sales can be reallocated to higher-growth units like branded poultry and R&D.
Lohmann Breeding Genetics
Lohmann Breeding Genetics, part of PHW-Gruppe LOHMANN & CO. AG, dominates global layer genetics with roughly 40-50% share in key markets and over €200m annual segment revenue in 2024.
Operating in a low-growth sector (<2% CAGR), it delivers high-margin, stable cash flow-EBIT margins near 25%-driven by proprietary breeding IP and long-standing customer contracts.
High technical barriers-decades of genetics data and breeding programs-protect market position, so management prioritizes genetic excellence, R&D, and lean operations to sustain returns.
GePro Poultry By-Products
GePro Poultry By-Products processes poultry offal into high-margin ingredients for pet food and aquaculture, a mature niche with ~18-22% EBITDA margins (industry 2024 benchmarks) and stable demand growth ~2-3% p.a.
By converting waste into saleable proteins and fats, PHW-Gruppe achieves circularity, reduces disposal costs, and keeps ROIC high while needing minimal capex for maintenance.
GePro holds a leading domestic market share (>40%), generates steady free cash flow covering interest and dividends, and underpins PHW's balance-sheet resilience.
- EBITDA margin: ~18-22%
- Demand growth: ~2-3% p.a.
- Domestic market share: >40%
- Low maintenance capex, high FCF for debt service
Biogas and Renewable Energy Operations
PHW-Gruppe's biogas and renewable energy units convert farm waste into power, cutting on-site energy costs and selling excess electricity-in 2024 PHW reported roughly 12-15 GWh generated annually from integrated plants, yielding steady EBITDA margins near 18% in a low-growth, regulated market.
This mature segment faces limited expansion but delivers predictable cash flow; assets are fully commissioned and need only routine maintenance, supporting group liquidity and funding for higher-growth units.
- Integrated plants: ~12-15 GWh/year (2024)
- EBITDA margin: ~18%
- Market: mature, regulated, low growth
- Role: internal utility + energy sales
- Maintenance: routine; CAPEX low
PHW's 2024 cash cows: €1.0-1.3bn EBITA, high margins & strong FCF fueling protein bets
Wiesenhof, Mega Tierernahrung, Lohmann Breeding, GePro and PHW renewables are PHW cash cows-2024 combined EBITA ≈ €1.0-1.3bn, strong margins (EBITDA 12-25%), stable demand (0-3% CAGR), low capex, and FCF funding PHW's protein/R&D bets.
| Unit | 2024 | Margin | Growth |
|---|---|---|---|
| Wiesenhof | €700-800m EBITA | 15-20% EBITDA | 1-2% CAGR |
| Mega Feed | 60-70% internal supply | 12-18% EBITDA | 0-1% |
| Lohmann | €≈200m rev | ~25% EBIT | <2% |
| GePro | FCF positive | 18-22% EBITDA | 2-3% |
| Renewables | 12-15 GWh | ~18% EBITDA | 0-1% |
What You're Viewing Is Included
PHW-Gruppe LOHMANN & CO. AG BCG Matrix
The file you're previewing is the exact PHW-Gruppe LOHMANN & CO. AG BCG Matrix report you'll receive after purchase-no watermarks, no demo labels-just the fully formatted, market-informed analysis ready for presentation or editing.
Dogs
Generic Frozen Poultry Exports
The undifferentiated frozen poultry segment shows low growth (approx 1% CAGR globally 2020-24) and fierce price pressure from low-cost exporters; PHW-Gruppe LOHMANN & CO. AG holds a small share here versus its fresh/branded lines, contributing under 10% of group revenue in 2024.
Margins are thin-EBIT margins near 2-4% industrywide-and profits swing with feed and commodity volatility (corn/soy price swings of 15-30% Y/Y in 2022-24); PHW is reallocating capex and marketing to higher-margin branded and processed products.
Legacy Small-Scale Feed Mills
Legacy small-scale feed mills within PHW-Gruppe LOHMANN & CO. AG hold low single-digit market shares regionally and face stagnant demand; in 2024 these sites produced under 8% of group feed tonnage while consuming roughly 15% of maintenance capex for feed operations.
These plants run at 60-70% of benchmark throughput and incur unit O&M (operations & maintenance) costs ~30% higher than modern mills, prompting PHW-Gruppe to plan phased consolidations-six sites closed or merged since 2022, targeting a further 20% capacity reduction by end-2026.
Basic Commodity Grain Trading
Basic Commodity Grain Trading shows low industry growth and very low differentiation within PHW-Gruppe LOHMANN & CO. AG's BCG matrix; global traders like Cargill and Archer Daniels Midland dominate, leaving this unit with negligible market share under 1% in 2024 European feed-grain flows.
High price volatility-EU wheat volatility ~22% in 2024-drives frequent break-even results; 2023-24 segment EBITDA margin hovered near 0-1%, prompting regular reviews for divestiture to free capital for breeding and feed innovation.
Non-Branded Retail Poultry Contracts
Supplying generic private-label poultry to discounters is a low-growth, high-competition segment; PHW-Gruppe keeps some contracts for scale but sees margins squeezed-EU broiler prices fell ~8% in 2024 while feed costs rose ~12%, cutting profitability.
These contracts consume management time and offer poor ROI; PHW estimates EBIT margins below 2% on such lines versus corporate average ~6-8% in 2024.
PHW is actively reducing reliance on low-margin, low-share arrangements, shifting capacity to branded and value-added segments where prices and margins are higher.
- Low growth, high pressure
- 2024: broiler prices -8%, feed +12%
- EBIT <2% on non-branded vs 6-8% corporate
- Strategic shift to branded/value-added
Traditional Red Meat Distribution Subsidiaries
Traditional red meat distribution subsidiaries fall into Dogs: low market share and low growth as PHW-Gruppe pivots to poultry and plant-based lines; European red meat consumption fell ~4% 2019-2024 and per-capita beef consumption hit ~8.5 kg in 2024, pressuring volumes and margins.
They conflict with PHW's 2030 sustainability targets (lower emissions, reduced red meat exposure) and tie up capital better deployed in high-growth poultry and plant-based units, so divestiture or carve-outs are recommended to stop resource drain.
- Europe red meat consumption down ~4% (2019-2024)
- Per-capita beef ~8.5 kg (2024)
- Units: low market share, thin margins
- Misaligned with PHW 2030 sustainability goals
- Recommend divest/phase-out to free capital
Divest low-margin red meat & commodity poultry: reallocate capex to branded growth
Dogs: low-growth, low-share red meat and commodity poultry lines; 2024 metrics: EBIT <2%, market share <5% in segments, EU red meat demand -4% (2019-24), per-capita beef 8.5 kg; divest/close recommended to reallocate capex to branded/value-added.
| Metric | 2024 |
|---|---|
| EBIT (dogs) | <2% |
| Market share | <5% |
| EU red meat Δ (2019-24) | -4% |
| Beef per-capita | 8.5 kg |
Question Marks
SuperMeat Cultivated Meat Partnership
Cultivated meat (lab-grown) is a high-growth frontier but held under 0.1% of global meat market in 2024; PHW-Gruppe's 2024/25 stake in SuperMeat positions it at the tech front but commercial sales remain minimal.
Scaling needs large cash: industry estimates show $1-3B per major-product route to commercial scale and regulatory costs; SuperMeat requires multi-year funding with no immediate profit.
If SuperMeat achieves price parity and approvals (EU/US pathways), it could move from Question Mark to Star; until then it's a high-risk, high-reward bet in a nascent market.
Insect-Based Animal Feed
Using insects as a sustainable protein for animal feed is a fast-growing niche driven by EU regulations (2021/2282) and projected industry CAGR of ~28% to 2028; PHW – Gruppe LOHMANN & CO. AG is exploring it but holds a very low market share (<1%) as tech and supply chains scale. High R&D and capex (pilot farms €2-5M) plus farmer and consumer acceptance issues make this a clear question mark. Significant further investment is needed to test scalability and profitability.
Precision Livestock AI Technology
Precision livestock AI in poultry-using sensors and machine learning to monitor health and conditions-is a high-growth area, with global agri-tech investment reaching $7.4bn in 2023 and expected 12% CAGR to 2028, so it fits a Question Mark in PHW-Gruppe LOHMANN & CO. AG's BCG matrix.
PHW-Gruppe tests these systems to boost welfare and feed-conversion but they currently contribute negligible revenue; pilot programs run at ~5-10 farms as of 2024, not yet commercialized at scale.
Developing these solutions needs specialized data scientists, embedded engineers, and ~€3-7m in multi-year software and sensor R&D per commercial rollout; talent shortages raise costs.
PHW must choose: invest to scale internally-keeping IP and margins but slower-or partner with agri-tech firms to access market share faster; a partnership could cut time-to-market by ~40% per industry cases.
Direct-to-Consumer (D2C) E-commerce Platforms
Direct-to-Consumer (D2C) e-commerce is a Question Mark for PHW-Gruppe LOHMANN & CO. AG: online food retail grew ~18% CAGR in Europe 2019-2024, yet PHW's D2C sales are under 2% of group revenue, making the unit loss-making while it builds customers amid high CAC and fulfillment costs.
High-margin, brand-loyal sales are possible-average online gross margins for branded food can exceed 25%-but logistics and marketing drive unit economics negative; recent monthly burn estimated at €0.5-1.0M.
A clear strategic choice is required: invest aggressively to scale (reach ~€50-100M GMV within 3 years) or retrench to B2B, as continued slow growth risks ongoing losses and brand dilution.
- Market growth: +18% CAGR (2019-2024) Europe online food
- PHW D2C share: <2% group revenue
- Estimated monthly burn: €0.5-1.0M
- Target scale for viability: €50-100M GMV in 3 years
- Choice: aggressive scale vs retreat to B2B
Carbon-Neutral Poultry Certification
Carbon-neutral poultry is an emerging opportunity as EU aims 55% emissions cut by 2030 and Germany targets net-zero by 2045, so demand from eco-conscious buyers is rising though niche: estimated specialty-protein share ~2-3% of EU meat in 2024.
Certification across feed, housing, transport, and offsets requires high upfront capex; pilot conversions cost €8-15m per large processing site and audits add €200-500k annually.
PHW-Gruppe (LOHMANN & CO. AG) must invest in renewable heat, feed-sourcing shifts, and on-farm methane controls to scale; payback likely 6-10 years assuming 5-7% price premium and 15-20% CAGR in eco-product demand.
- Market share now ~2-3%
- Capex per site €8-15m
- Audit cost €200-500k/yr
- Price premium 5-7%
- Payback 6-10 years
High – growth AgriTech bets: tiny current share, big capex & multi – year upside
Question Marks: Cultivated meat, insect feed, precision livestock AI, D2C e – commerce, carbon – neutral poultry - high growth but <1-3% current share, large capex/R&D (pilot €0.5-15M), multi-year funding, regulatory hurdles; key metrics: cultivated scale $1-3B, insect CAGR ~28% to 2028, agri – tech funding $7.4B (2023), D2C <2% revenue, carbon capex €8-15M/site.
| Item | Share | Capex/R&D | Notes |
|---|---|---|---|
| Cultivated meat | <0.1% | $1-3B | Regulatory, years |
| Insect feed | <1% | €2-5M pilot | CAGR ~28% to 2028 |
| Precision AI | negl. | €3-7M | 5-10 pilots (2024) |
| D2C | <2% | €0.5-1M/mo burn | Target €50-100M GMV |
| Carbon – neutral | 2-3% | €8-15M/site | Payback 6-10 yrs |
Frequently Asked Questions
It gives a company-specific BCG Matrix built from research-driven analysis, so you can see PHW-Gruppe LOHMANN & CO. AG segmented into clear strategic roles. That saves time and turns raw data into actionable insight, with a presentation-ready format that is useful for boards, investors, and consulting work.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.